Literature DB >> 2676503

Long-term hematopoietic damage: concepts, approaches, and results relevant to the study of environmental toxins.

N G Testa1, T M Dexter.   

Abstract

The hematopoietic tissue is one of the prime examples of hierarchical tissues, where mature cells with a limited life span are continually replaced as a result of proliferation and differentiation from stem and progenitor cells. In the bone marrow, these processes are controlled by growth factors and by cell to cell interactions, the latter being specially important for the regulation of the stem-cell population. In the study of long-term hematopoietic damage, we have to distinguish between deleterious effects of the environmental toxins on the stem and progenitor cells, and on the stromal bone marrow cells which are part of the regulatory hematopoietic microenvironment. In some experimental situations, the function of the tissue may be subnormal, not because of stem cell damage (which may also be present), but because of damage to regulatory environmental populations. Because of the high degree of organization of the hematopoietic tissue (not immediately obvious from histological sections), the heterogeneity of the stromal cell populations, and their different capacities to regenerate after cytotoxic insult, the stromal damage is likely to be heterogeneous and would tend to be expressed functionally at later times than acute hematopoietic injury. While microenvironmental damage may be of importance in the induction of hematopoietic failure, the primary target in leukemogenesis is likely to be the stem cell. However, experimental data support the concept that regulatory microenvironmental influences may hinder or favor the development of leukemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676503      PMCID: PMC1568120          DOI: 10.1289/ehp.898251

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  29 in total

1.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

2.  The growth of mouse bone marrow cells in vitro.

Authors:  T R Bradley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

3.  Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice.

Authors:  J E Dick; M C Magli; D Huszar; R A Phillips; A Bernstein
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

4.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

5.  Colony formation in agar by multipotential hemopoietic cells.

Authors:  D Metcalf; G R Johnson; T E Mandel
Journal:  J Cell Physiol       Date:  1979-02       Impact factor: 6.384

6.  Studies on the regulation of hemopoietic spleen colonies.

Authors:  I Bleiberg; M Liron; M Feldman
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

7.  An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.

Authors:  A Morley; J Blake
Journal:  Blood       Date:  1974-07       Impact factor: 22.113

8.  Bone marrow fibroblast function in relation to granulopoiesis in aplastic anaemia.

Authors:  M Y Gordon; E C Gordon-Smith
Journal:  Br J Haematol       Date:  1983-03       Impact factor: 6.998

9.  Functional changes in marrow stromal cells in aplastic anaemia.

Authors:  T Hotta; T Kato; H Maeda; H Yamao; H Yamada; H Saito
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

10.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure.

Authors:  D E Harrison; C M Astle
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.